Active Biotech Ab (publ)(FRA) BTPC

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

N/A

Active Biotech Ab (publ) Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.08

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

BTPC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Active Biotech Ab (publ)

Active Biotech AB engages in the development of pharmaceutical products. The firm specializes in the medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease, and various forms of cancer. Its portfolio comprises orally active immunomodulatory molecules as well as antibody-based immunotherapy. The company was founded on June 15, 1982 and is headquartered in Lund, Sweden.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Helén Tuvesson, PhD

Website

www.activebiotech.com

BTPC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Active Biotech Ab (publ) Performance Analysis

Active Biotech Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Active Biotech Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.76	5.6%
2023	2023-12-31	USD -0.53	-30.4%
2024	2024-12-31	USD -0.65	23.5%
2025	2025-12-31	USD -0.25	-61.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.04

+1.0%

Gross Margin

N/A

Market Cap

N/A

Market Cap/Employee

$4.48

+0.6%

Employees

+1.0%

Net Income

-$0.93

+0.9%

EBITDA

-$0.90

+0.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$3.98

+152.8%

Total Debt

$0.01

+0.1%

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.01

+0.1%

Short Term Debt

$0.00

N/A

Return on Assets

-97.00%

+0.5%

Return on Invested Capital

-115.39%

+0.9%

Free Cash Flow

-$0.81

+1.0%

Operating Cash Flow

-$0.81

+1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$82.52-0.00%

Questions About BTPC

What is the current price of Active Biotech Ab (publ)?

Active Biotech Ab (publ) is trading at N/A per share.

What is the 52-week range for Active Biotech Ab (publ)?

Over the past 52 weeks, Active Biotech Ab (publ) has traded between N/A and N/A.

How much debt does Active Biotech Ab (publ) have?

As of the most recent reporting period, Active Biotech Ab (publ) reported total debt of $9.04K.

How much cash does Active Biotech Ab (publ) have on hand?

Active Biotech Ab (publ) reported $3.97M in cash and cash equivalents in its most recent financial results.

What is Active Biotech Ab (publ)’s dividend yield?

Active Biotech Ab (publ) does not currently have a dividend yield.

Active Biotech Ab (publ)(FRA) BTPC

Active Biotech Ab (publ) Financials at a Glance

BTPC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Active Biotech Ab (publ)

BTPC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Active Biotech Ab (publ) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BTPC

What is the current price of Active Biotech Ab (publ)?

What is the 52-week range for Active Biotech Ab (publ)?

How much debt does Active Biotech Ab (publ) have?

How much cash does Active Biotech Ab (publ) have on hand?

What is Active Biotech Ab (publ)’s dividend yield?

Premium Investing Services